Core Viewpoint - The collaboration between Xiaofang Pharmaceutical and Boji Pharmaceutical Technology Co., Ltd. aims to enhance the clinical research and registration of a new traditional Chinese medicine product, thereby improving the efficiency and success rate of the development process [1] Group 1: Company Collaboration - Xiaofang Pharmaceutical has signed a technology entrustment contract with Boji Pharmaceutical to assist in the clinical research and registration of a Class 1 compound medicine [1] - Boji Pharmaceutical is recognized as an industry leader with significant advantages in research and development capabilities, technical accumulation, and clinical resources [1] - The partnership is expected to leverage the strengths of both companies, creating a synergistic effect that will solidify the foundation for subsequent product application and market launch [1]
小方制药委托博济医药开发中药1.1类新药复方侧柏酊